Literature DB >> 26436548

Involvement of Neuroactive Steroids in Pain, Depression and Anxiety.

Katherine Mifflin, Curtis Benson, Bradley Kerr, Feyza Aricioglu, Mesut Cetin, Serdar Dursun, Glen Baker.   

Abstract

Comorbidity between major depressive disorder (MDD), anxiety (generalized anxiety, panic disorder, social anxiety disorder) and pain is a major complicating factor in the diagnosis and treatment of psychiatric and neurological disorders. Although numerous neurotransmitters and/or neuromodulators may be involved, abnormalities in the GABAergic and glutamatergic systems seem to be a common factor in all these disorders. Neuroactive steroids (NASs) have been the object of considerable interest in this area in recent years since they appear to act predominantly on GABA-A and glutamate NMDA receptors. An overview of the possible involvement of NASs in MDD, anxiety and pain is provided in this chapter.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26436548     DOI: 10.1159/000435935

Source DB:  PubMed          Journal:  Mod Trends Pharmacopsychiatry        ISSN: 0077-0094


  7 in total

Review 1.  Pharmacological Management of Chronic Pelvic Pain in Women.

Authors:  Erin T Carey; Sara R Till; Sawsan As-Sanie
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Chronic pain in adolescence and internalizing mental health disorders: a nationally representative study.

Authors:  Melanie Noel; Cornelius B Groenewald; Sarah E Beals-Erickson; J Thomas Gebert; Tonya M Palermo
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

3.  Hemodynamic variability in soldiers with trauma: Implications for functional MRI connectivity studies.

Authors:  D Rangaprakash; Michael N Dretsch; Wenjing Yan; Jeffrey S Katz; Thomas S Denney; Gopikrishna Deshpande
Journal:  Neuroimage Clin       Date:  2017-07-25       Impact factor: 4.881

4.  Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents.

Authors:  Jessica A Waller; Sara Holm Nygaard; Yan Li; Kristian Gaarn du Jardin; Joseph A Tamm; Aicha Abdourahman; Betina Elfving; Alan L Pehrson; Connie Sánchez; Rasmus Wernersson
Journal:  BMC Neurosci       Date:  2017-08-04       Impact factor: 3.288

Review 5.  Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases.

Authors:  Minyu Zhang; Liping Xu; Hongjun Yang
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

Review 6.  Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.

Authors:  Carmen Gimeno; Marisa Luisa Dorado; Carlos Roncero; Nestor Szerman; Pablo Vega; Vicent Balanzá-Martínez; F Javier Alvarez
Journal:  Front Psychiatry       Date:  2017-09-22       Impact factor: 4.157

7.  Contribution of central sensitization to stress-induced spreading hyperalgesia in rats with orofacial inflammation.

Authors:  Jia-Heng Li; Jia-Le Yang; Si-Qi Wei; Zhuo-Lin Li; Anna A Collins; Min Zou; Feng Wei; Dong-Yuan Cao
Journal:  Mol Brain       Date:  2020-07-28       Impact factor: 4.399

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.